Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B

K. Vališ, V. Grobárová, L. Hernychová, M. Bugáňová, D. Kavan, M. Kalous, J. Černý, E. Stodůlková, M. Kuzma, M. Flieger, J. Černý, P. Novák,

. 2017 ; 8 (61) : 103137-103153. [pub] 20171007

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18000876

Abnormalities in cancer metabolism represent potential targets for cancer therapy. We have recently identified a natural compound Quambalarine B (QB), which inhibits proliferation of several leukemic cell lines followed by cell death. We have predicted ubiquinone binding sites of mitochondrial respiratory complexes as potential molecular targets of QB in leukemia cells. Hence, we tracked the effect of QB on leukemia metabolism by applying several omics and biochemical techniques. We have confirmed the inhibition of respiratory complexes by QB and found an increase in the intracellular AMP levels together with respiratory substrates. Inhibition of mitochondrial respiration by QB triggered reprogramming of leukemic cell metabolism involving disproportions in glycolytic flux, inhibition of proteins O-glycosylation, stimulation of glycine synthesis pathway, and pyruvate kinase activity, followed by an increase in pyruvate and a decrease in lactate levels. Inhibition of mitochondrial complex I by QB suppressed folate metabolism as determined by a decrease in formate production. We have also observed an increase in cellular levels of several amino acids except for aspartate, indicating the dependence of Jurkat (T-ALL) cells on aspartate synthesis. These results indicate blockade of mitochondrial complex I and II activity by QB and reduction in aspartate and folate metabolism as therapeutic targets in T-ALL cells. Anti-cancer activity of QB was also confirmed during in vivo studies, suggesting the therapeutic potential of this natural compound.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18000876
003      
CZ-PrNML
005      
20180116121253.0
007      
ta
008      
180116s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.18632/oncotarget.21663 $2 doi
035    __
$a (PubMed)29262552
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vališ, Karel $u BIOCEV, Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Vestec, Czech Republic. Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.
245    10
$a Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B / $c K. Vališ, V. Grobárová, L. Hernychová, M. Bugáňová, D. Kavan, M. Kalous, J. Černý, E. Stodůlková, M. Kuzma, M. Flieger, J. Černý, P. Novák,
520    9_
$a Abnormalities in cancer metabolism represent potential targets for cancer therapy. We have recently identified a natural compound Quambalarine B (QB), which inhibits proliferation of several leukemic cell lines followed by cell death. We have predicted ubiquinone binding sites of mitochondrial respiratory complexes as potential molecular targets of QB in leukemia cells. Hence, we tracked the effect of QB on leukemia metabolism by applying several omics and biochemical techniques. We have confirmed the inhibition of respiratory complexes by QB and found an increase in the intracellular AMP levels together with respiratory substrates. Inhibition of mitochondrial respiration by QB triggered reprogramming of leukemic cell metabolism involving disproportions in glycolytic flux, inhibition of proteins O-glycosylation, stimulation of glycine synthesis pathway, and pyruvate kinase activity, followed by an increase in pyruvate and a decrease in lactate levels. Inhibition of mitochondrial complex I by QB suppressed folate metabolism as determined by a decrease in formate production. We have also observed an increase in cellular levels of several amino acids except for aspartate, indicating the dependence of Jurkat (T-ALL) cells on aspartate synthesis. These results indicate blockade of mitochondrial complex I and II activity by QB and reduction in aspartate and folate metabolism as therapeutic targets in T-ALL cells. Anti-cancer activity of QB was also confirmed during in vivo studies, suggesting the therapeutic potential of this natural compound.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Grobárová, Valéria $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Hernychová, Lucie $u BIOCEV, Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Vestec, Czech Republic. Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Bugáňová, Martina $u Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Prague, Czech Republic. Faculty of Chemical Technology, University of Chemistry and Technology, Prague, Czech Republic.
700    1_
$a Kavan, Daniel $u Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic. Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Kalous, Martin $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Černý, Jiří $u BIOCEV, Institute of Biotechnology, v.v.i., The Czech Academy of Sciences, Vestec, Czech Republic.
700    1_
$a Stodůlková, Eva $u Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Kuzma, Marek $u Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Flieger, Miroslav $u Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Černý, Jan $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Novák, Petr $u BIOCEV, Institute of Microbiology, v.v.i., The Czech Academy of Sciences, Vestec, Czech Republic. Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.
773    0_
$w MED00184852 $t Oncotarget $x 1949-2553 $g Roč. 8, č. 61 (2017), s. 103137-103153
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29262552 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180116 $b ABA008
991    __
$a 20180116121526 $b ABA008
999    __
$a ind $b bmc $g 1268271 $s 997538
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 8 $c 61 $d 103137-103153 $e 20171007 $i 1949-2553 $m Oncotarget $n Oncotarget $x MED00184852
LZP    __
$a Pubmed-20180116
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace